Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:35602299

A N7-Methylguanine-Related Gene Signature Applicable for the Prognosis and Microenvironment of Prostate Cancer.

Wangli Mei · Xuyang Jia · Shiyong Xin · Xiang Liu · Liang Jin · Xianchao Sun · Jia-Xin Zhang · Bihui Zhang · Guosheng Yang · Ping Chen · Lin Ye

Journal of oncology · 2022 doi:10.1155/2022/8604216

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:35602299
kind
science-record
content_hash
sha256:89bc3fbe13d41b5cd39d522a4e84571adad073fb89bfa3bfe9410983bc673ede
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T18:14:30Z
updated_at
2026-11-01T22:06:34Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
A N7-Methylguanine-Related Gene Signature Applicable for the Prognosis and Microenvironment of Prostate Cancer.
doi
10.1155/2022/8604216
pmid
35602299
authors array · 11 items
[0]
Wangli Mei
[1]
Xuyang Jia
[2]
Shiyong Xin
[3]
Xiang Liu
[4]
Liang Jin
[5]
Xianchao Sun
[6]
Jia-Xin Zhang
[7]
Bihui Zhang
[8]
Guosheng Yang
[9]
Ping Chen
[10]
Lin Ye
journal
Journal of oncology
year
2022
abstract
Background: Despite the constant iteration of small-molecule inhibitors and immune checkpoint inhibitors, PRAD (prostate adenocarcinoma) patients with distant metastases and biochemical recurrence maintain a poor survival outcome along with an increasing morbidity in recent years. N7-Methylguanine, a new-found type of RNA modification, has demonstrated an essential role in tumor progression but has hardly been studied for its effect on prostate carcinoma. The current study aimed to seek m7G (N7-methylguanosine) related prognostic biomarkers and potential targets for PRAD treatment. Methods: 42 genes related to m7G were collected from former literatures and GSEA (Gene Set Enrichment Analysis) website. Then, RNA-seq (RNA sequencing) and clinical data from TCGA-PRAD (The Cancer Genome Atlas-Prostate) cohort were retrieved to screen the differentially expressed m7G genes to further construct a multivariate Cox prognostic model for PRAD. Next, GSE116918, a prostate cancer cohort acquired from GEO (Gene Expression Omnibus) database, was analyzed for the external validation group to assess the ability to predict BFFS (biochemical failure-free survival) of our m7G prognostic signature. Kaplan-Meier, ROC (receiver operator characteristic), AUC (areas under ROC curve), and calibration curves were adopted to display the performance of this prognostic signature. In addition, immune infiltration analysis was implemented to evaluate the effect of these m7G genes on immunoinfiltrating cells. Correlation with drug susceptibility of the m7G signature was also analyzed by matching drug information in CellMiner database. Results: The m7G-related prognostic signature, including three genes (EIF3D, EIF4A1, LARP1) illustrated superior prognostic ability for PRAD in both training and validation cohorts. The 5-year AUC were 0.768 for TCGA-PRAD and 0.608 for GSE116918. It can well distinguish patients into different risk groups of biochemical recurrence (p =1e-04 for TCGA-PRAD and p =0.0186 for GSE116918). Immune infiltration analysis suggested potential regulation of m7G genes on neutrophils and dendritic cells in PRAD. Conclusions: A m7G-related prognostic signature was constructed and validated in the current study, giving new sights of m7G methylation in predicting the prognostic and improving the treatment of PRAD.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
Then, lasso (least absolute shrinkage and selection operator) [23] Cox regression analysis was adopted for this prognostic signature construction by using R package “glmnet.”
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35602299
locator
sections[4] "2.2. Analysis and Validation of Our Prognostic Signature" paragraph 2
quote
Then, lasso (least absolute shrinkage and selection operator) [23] Cox regression analysis was adopted for this prognostic signature construction by using R package “glmnet.”
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The data could be acquired from TCGA dataset (https://portal.gdc.cancer.gov/) and GEO dataset (https://www.ncbi.nlm.nih.gov/geo/). The data of drug sensitivity could be acquired from the CellMiner database (https://discover.nci.nih.gov/cellminer). The code used in the study is available from the corresponding author on reasonable request.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35602299
locator
sections[23] "Data Availability" paragraph 2
quote
The data could be acquired from TCGA dataset (https://portal.gdc.cancer.gov/) and GEO dataset (https://www.ncbi.nlm.nih.gov/geo/). The data of drug sensitivity could be acquired from the CellMiner database (https://discover.nci.nih.gov/cellminer). The code used in the study is available from the corresponding author on reasonable request.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
The m7G-related prognostic signature, including three genes (EIF3D, EIF4A1, LARP1) illustrated superior prognostic ability for PRAD in both training and validation cohorts.
kind
qualitative
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:35602299
locator
sections[0] "Abstract" paragraph 3
quote
The m7G-related prognostic signature, including three genes (EIF3D, EIF4A1, LARP1) illustrated superior prognostic ability for PRAD in both training and validation cohorts.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
The m7G-related prognostic signature, including three genes (EIF3D, EIF4A1, LARP1) illustrated superior prognostic ability for PRAD in both training and validation cohorts.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:35602299
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE116918
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE116918
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 2 items
[0] object · 15 fields
id
source:pmid:35602299
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1155/2022/8604216
sha256
sha256:7dd6f8d8bedb3ca6b833eeb4e426335d78bc831972492f1e563b1c38fa7fa0ab
bytes
39846
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1155/2022/8604216
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC9122703
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE116918
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116918
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE116918
version
null
note
The data could be acquired from TCGA dataset (https://portal.gdc.cancer.gov/) and GEO dataset (https://www.ncbi.nlm.nih.gov/geo/). The data of drug sensitivity could be acquired from the CellMiner database (https://discover.nci.nih.gov/cellminer). The code used in the study is available from the corresponding author on reasonable request.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The data could be acquired from TCGA dataset (https://portal.gdc.cancer.gov/) and GEO dataset (https://www.ncbi.nlm.nih.gov/geo/). The data of drug sensitivity could be acquired from the CellMiner database (https://discover.nci.nih.gov/cellminer). The code used in the study is available from the corresponding author on reasonable request.
access_statement_kind
data_availability_statement
sample_accessions array · 248 items
[0]
GSM3263664
[1]
GSM3263665
[2]
GSM3263666
[3]
GSM3263667
[4]
GSM3263668
[5]
GSM3263669
[6]
GSM3263670
[7]
GSM3263671
[8]
GSM3263672
[9]
GSM3263673
[10]
GSM3263674
[11]
GSM3263675
[12]
GSM3263676
[13]
GSM3263677
[14]
GSM3263678
[15]
GSM3263679
[16]
GSM3263680
[17]
GSM3263681
[18]
GSM3263682
[19]
GSM3263683
[20]
GSM3263684
[21]
GSM3263685
[22]
GSM3263686
[23]
GSM3263687
[24]
GSM3263688
[25]
GSM3263689
[26]
GSM3263690
[27]
GSM3263691
[28]
GSM3263692
[29]
GSM3263693
[30]
GSM3263694
[31]
GSM3263695
[32]
GSM3263696
[33]
GSM3263697
[34]
GSM3263698
[35]
GSM3263699
[36]
GSM3263700
[37]
GSM3263701
[38]
GSM3263702
[39]
GSM3263703
[40]
GSM3263704
[41]
GSM3263705
[42]
GSM3263706
[43]
GSM3263707
[44]
GSM3263708
[45]
GSM3263709
[46]
GSM3263710
[47]
GSM3263711
[48]
GSM3263712
[49]
GSM3263713
[50]
GSM3263714
[51]
GSM3263715
[52]
GSM3263716
[53]
GSM3263717
[54]
GSM3263718
[55]
GSM3263719
[56]
GSM3263720
[57]
GSM3263721
[58]
GSM3263722
[59]
GSM3263723
[60]
GSM3263724
[61]
GSM3263725
[62]
GSM3263726
[63]
GSM3263727
[64]
GSM3263728
[65]
GSM3263729
[66]
GSM3263730
[67]
GSM3263731
[68]
GSM3263732
[69]
GSM3263733
[70]
GSM3263734
[71]
GSM3263735
[72]
GSM3263736
[73]
GSM3263737
[74]
GSM3263738
[75]
GSM3263739
[76]
GSM3263740
[77]
GSM3263741
[78]
GSM3263742
[79]
GSM3263743
[80]
GSM3263744
[81]
GSM3263745
[82]
GSM3263746
[83]
GSM3263747
[84]
GSM3263748
[85]
GSM3263749
[86]
GSM3263750
[87]
GSM3263751
[88]
GSM3263752
[89]
GSM3263753
[90]
GSM3263754
[91]
GSM3263755
[92]
GSM3263756
[93]
GSM3263757
[94]
GSM3263758
[95]
GSM3263759
[96]
GSM3263760
[97]
GSM3263761
[98]
GSM3263762
[99]
GSM3263763
[100]
GSM3263764
[101]
GSM3263765
[102]
GSM3263766
[103]
GSM3263767
[104]
GSM3263768
[105]
GSM3263769
[106]
GSM3263770
[107]
GSM3263771
[108]
GSM3263772
[109]
GSM3263773
[110]
GSM3263774
[111]
GSM3263775
[112]
GSM3263776
[113]
GSM3263777
[114]
GSM3263778
[115]
GSM3263779
[116]
GSM3263780
[117]
GSM3263781
[118]
GSM3263782
[119]
GSM3263783
[120]
GSM3263784
[121]
GSM3263785
[122]
GSM3263786
[123]
GSM3263787
[124]
GSM3263788
[125]
GSM3263789
[126]
GSM3263790
[127]
GSM3263791
[128]
GSM3263792
[129]
GSM3263793
[130]
GSM3263794
[131]
GSM3263795
[132]
GSM3263796
[133]
GSM3263797
[134]
GSM3263798
[135]
GSM3263799
[136]
GSM3263800
[137]
GSM3263801
[138]
GSM3263802
[139]
GSM3263803
[140]
GSM3263804
[141]
GSM3263805
[142]
GSM3263806
[143]
GSM3263807
[144]
GSM3263808
[145]
GSM3263809
[146]
GSM3263810
[147]
GSM3263811
[148]
GSM3263812
[149]
GSM3263813
[150]
GSM3263814
[151]
GSM3263815
[152]
GSM3263816
[153]
GSM3263817
[154]
GSM3263818
[155]
GSM3263819
[156]
GSM3263820
[157]
GSM3263821
[158]
GSM3263822
[159]
GSM3263823
[160]
GSM3263824
[161]
GSM3263825
[162]
GSM3263826
[163]
GSM3263827
[164]
GSM3263828
[165]
GSM3263829
[166]
GSM3263830
[167]
GSM3263831
[168]
GSM3263832
[169]
GSM3263833
[170]
GSM3263834
[171]
GSM3263835
[172]
GSM3263836
[173]
GSM3263837
[174]
GSM3263838
[175]
GSM3263839
[176]
GSM3263840
[177]
GSM3263841
[178]
GSM3263842
[179]
GSM3263843
[180]
GSM3263844
[181]
GSM3263845
[182]
GSM3263846
[183]
GSM3263847
[184]
GSM3263848
[185]
GSM3263849
[186]
GSM3263850
[187]
GSM3263851
[188]
GSM3263852
[189]
GSM3263853
[190]
GSM3263854
[191]
GSM3263855
[192]
GSM3263856
[193]
GSM3263857
[194]
GSM3263858
[195]
GSM3263859
[196]
GSM3263860
[197]
GSM3263861
[198]
GSM3263862
[199]
GSM3263863
[200]
GSM3263864
[201]
GSM3263865
[202]
GSM3263866
[203]
GSM3263867
[204]
GSM3263868
[205]
GSM3263869
[206]
GSM3263870
[207]
GSM3263871
[208]
GSM3263872
[209]
GSM3263873
[210]
GSM3263874
[211]
GSM3263875
[212]
GSM3263876
[213]
GSM3263877
[214]
GSM3263878
[215]
GSM3263879
[216]
GSM3263880
[217]
GSM3263881
[218]
GSM3263882
[219]
GSM3263883
[220]
GSM3263884
[221]
GSM3263885
[222]
GSM3263886
[223]
GSM3263887
[224]
GSM3263888
[225]
GSM3263889
[226]
GSM3263890
[227]
GSM3263891
[228]
GSM3263892
[229]
GSM3263893
[230]
GSM3263894
[231]
GSM3263895
[232]
GSM3263896
[233]
GSM3263897
[234]
GSM3263898
[235]
GSM3263899
[236]
GSM3263900
[237]
GSM3263901
[238]
GSM3263902
[239]
GSM3263903
[240]
GSM3263904
[241]
GSM3263905
[242]
GSM3263906
[243]
GSM3263907
[244]
GSM3263908
[245]
GSM3263909
[246]
GSM3263910
[247]
GSM3263911
sample_count
248
group_sizes
null
group_sizes_basis
null
platform
25318
taxon
Homo sapiens
title
Using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 2 items
[0]
asset:data:geo:GSE116918 not downloaded
[1]
asset:data:geo:GSE116918 licence not read
analysis object · 4 fields
state
complete
methods array · 3 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
Then, lasso (least absolute shrinkage and selection operator) [23] Cox regression analysis was adopted for this prognostic signature construction by using R package “glmnet.”
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Kaplan-Meier
[2] object · 10 fields
id
method-3
family
diagnostic_evaluation
specific
roc
label
Diagnostic test evaluation
dsl_operations array · 6 items
[0]
confusion_counts
[1]
roc_curve
[2]
sensitivity_specificity
[3]
solve_confusion_matrix
[4]
classification_metrics
[5]
published_precision_envelope
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
reference_standard_and_test
evidence object · 3 fields
score
0.7
band
medium
quote
ROC curve
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
GSE116918
resolved_accessions array · 1 item
[0]
GSE116918
statements array · 1 item
[0]
The data could be acquired from TCGA dataset (https://portal.gdc.cancer.gov/) and GEO dataset (https://www.ncbi.nlm.nih.gov/geo/). The data of drug sensitivity could be acquired from the CellMiner database (https://discover.nci.nih.gov/cellminer). The code used in the study is available from the corresponding author on reasonable request.
basis
The paper names GSE116918 in GEO and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
cox_ph
assets array · 2 items
[0]
source:pmid:35602299
[1]
data:geo:GSE116918
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE116918
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T17:47:02Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
12677
completion_tokens
3033
cached_tokens
256
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:35602299
type
paper
label
pmid:35602299
[1] object · 3 fields
id
source:pmid:35602299
type
manuscript
label
PMID 35602299 full text
[2] object · 3 fields
id
data:geo:GSE116918
type
dataset
label
GEO GSE116918
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:35602299
type
paper
label
pmid:35602299
[1] object · 3 fields
id
source:pmid:35602299
type
manuscript
label
PMID 35602299 full text
[2] object · 3 fields
id
data:geo:GSE116918
type
dataset
label
GEO GSE116918
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-35602299
type
extraction
used array · 1 item
[0]
source:pmid:35602299
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE116918
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE116918
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:35602299
parent_hash
sha256:509d453f1ddf21ae7fcbcb0ab76ed30304387b6576c4f5b7c798b260990a3253
fork_of
null
gaps array · 6 items
[0]
asset:data:geo:GSE116918 licence not read
[1]
asset:data:geo:GSE116918 not downloaded
[2]
execution.not_run
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_id
rna_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
Gene Set Enrichment Analysis) website. Then, RNA-seq (RNA sequencing) and clinical data from TCGA
[1]
Enrichment Analysis) website. Then, RNA-seq (RNA sequencing) and clinical data from TCGA-PRAD (The Cance
order_basis
paper_text_order:783
id
assay:1
[1] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.93
evidence array · 1 item
[0]
signature and clinical features of PRAD. (g) Immunohistochemistry figures from The Human Protein Atlas databas
order_basis
paper_text_order:3500
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
cox_ph
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Then, lasso (least absolute shrinkage and selection operator) [23] Cox regression analysis was adopted for this prognostic signature construction by using R package “glmnet.”
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:35602299", "kind": "science-record", "revision": 4, "content_hash": "sha256:89bc3fbe13d41b5cd39d522a4e84571adad073fb89bfa3bfe9410983bc673ede", "created_at": "2026-11-01T18:14:30Z", "updated_at": "2026-11-01T22:06:34Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "A N7-Methylguanine-Related Gene Signature Applicable for the Prognosis and Microenvironment of Prostate Cancer.", "doi": "10.1155/2022/8604216", "pmid": "35602299", "authors": ["Wangli Mei", "Xuyang Jia", "Shiyong Xin", "Xiang Liu", "Liang Jin", "Xianchao Sun", "Jia-Xin Zhang", "Bihui Zhang", "Guosheng Yang", "Ping Chen", "Lin Ye"], "journal": "Journal of oncology", "year": 2022, "abstract": "Background: Despite the constant iteration of small-molecule inhibitors and immune checkpoint inhibitors, PRAD (prostate adenocarcinoma) patients with distant metastases and biochemical recurrence maintain a poor survival outcome along with an increasing morbidity in recent years. N7-Methylguanine, a new-found type of RNA modification, has demonstrated an essential role in tumor progression but has hardly been studied for its effect on prostate carcinoma. The current study aimed to seek m7G (N7-methylguanosine) related prognostic biomarkers and potential targets for PRAD treatment.\nMethods: 42 genes related to m7G were collected from former literatures and GSEA (Gene Set Enrichment Analysis) website. Then, RNA-seq (RNA sequencing) and clinical data from TCGA-PRAD (The Cancer Genome Atlas-Prostate) cohort were retrieved to screen the differentially expressed m7G genes to further construct a multivariate Cox prognostic model for PRAD. Next, GSE116918, a prostate cancer cohort acquired from GEO (Gene Expression Omnibus) database, was analyzed for the external validation group to assess the ability to predict BFFS (biochemical failure-free survival) of our m7G prognostic signature. Kaplan-Meier, ROC (receiver operator characteristic), AUC (areas under ROC curve), and calibration curves were adopted to display the performance of this prognostic signature. In addition, immune infiltration analysis was implemented to evaluate the effect of these m7G genes on immunoinfiltrating cells. Correlation with drug susceptibility of the m7G signature was also analyzed by matching drug information in CellMiner database.\nResults: The m7G-related prognostic signature, including three genes (EIF3D, EIF4A1, LARP1) illustrated superior prognostic ability for PRAD in both training and validation cohorts. The 5-year AUC were 0.768 for TCGA-PRAD and 0.608 for GSE116918. It can well distinguish patients into different risk groups of biochemical recurrence (p =1e-04 for TCGA-PRAD and p =0.0186 for GSE116918). Immune infiltration analysis suggested potential regulation of m7G genes on neutrophils and dendritic cells in PRAD.\nConclusions: A m7G-related prognostic signature was constructed and validated in the current study, giving new sights of m7G methylation in predicting the prognostic and improving the treatment of PRAD.", "claims": [{"id": "claim-method", "statement": "Then, lasso (least absolute shrinkage and selection operator) [23] Cox regression analysis was adopted for this prognostic signature construction by using R package “glmnet.”", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35602299", "locator": "sections[4] \"2.2. Analysis and Validation of Our Prognostic Signature\" paragraph 2", "quote": "Then, lasso (least absolute shrinkage and selection operator) [23] Cox regression analysis was adopted for this prognostic signature construction by using R package “glmnet.”"}], "state": "complete"}, {"id": "claim-data-access", "statement": "The data could be acquired from TCGA dataset (https://portal.gdc.cancer.gov/) and GEO dataset (https://www.ncbi.nlm.nih.gov/geo/). The data of drug sensitivity could be acquired from the CellMiner database (https://discover.nci.nih.gov/cellminer). The code used in the study is available from the corresponding author on reasonable request.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35602299", "locator": "sections[23] \"Data Availability\" paragraph 2", "quote": "The data could be acquired from TCGA dataset (https://portal.gdc.cancer.gov/) and GEO dataset (https://www.ncbi.nlm.nih.gov/geo/). The data of drug sensitivity could be acquired from the CellMiner database (https://discover.nci.nih.gov/cellminer). The code used in the study is available from the corresponding author on reasonable request."}], "state": "complete"}, {"id": "claim-target-result", "statement": "The m7G-related prognostic signature, including three genes (EIF3D, EIF4A1, LARP1) illustrated superior prognostic ability for PRAD in both training and validation cohorts.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:35602299", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "The m7G-related prognostic signature, including three genes (EIF3D, EIF4A1, LARP1) illustrated superior prognostic ability for PRAD in both training and validation cohorts."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "The m7G-related prognostic signature, including three genes (EIF3D, EIF4A1, LARP1) illustrated superior prognostic ability for PRAD in both training and validation cohorts.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:35602299"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE116918"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE116918"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:35602299", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1155/2022/8604216", "sha256": "sha256:7dd6f8d8bedb3ca6b833eeb4e426335d78bc831972492f1e563b1c38fa7fa0ab", "bytes": 39846, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1155/2022/8604216", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC9122703", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE116918", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116918", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE116918", "version": null, "note": "The data could be acquired from TCGA dataset (https://portal.gdc.cancer.gov/) and GEO dataset (https://www.ncbi.nlm.nih.gov/geo/). The data of drug sensitivity could be acquired from the CellMiner database (https://discover.nci.nih.gov/cellminer). The code used in the study is available from the corresponding author on reasonable request.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The data could be acquired from TCGA dataset (https://portal.gdc.cancer.gov/) and GEO dataset (https://www.ncbi.nlm.nih.gov/geo/). The data of drug sensitivity could be acquired from the CellMiner database (https://discover.nci.nih.gov/cellminer). The code used in the study is available from the corresponding author on reasonable request.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM3263664", "GSM3263665", "GSM3263666", "GSM3263667", "GSM3263668", "GSM3263669", "GSM3263670", "GSM3263671", "GSM3263672", "GSM3263673", "GSM3263674", "GSM3263675", "GSM3263676", "GSM3263677", "GSM3263678", "GSM3263679", "GSM3263680", "GSM3263681", "GSM3263682", "GSM3263683", "GSM3263684", "GSM3263685", "GSM3263686", "GSM3263687", "GSM3263688", "GSM3263689", "GSM3263690", "GSM3263691", "GSM3263692", "GSM3263693", "GSM3263694", "GSM3263695", "GSM3263696", "GSM3263697", "GSM3263698", "GSM3263699", "GSM3263700", "GSM3263701", "GSM3263702", "GSM3263703", "GSM3263704", "GSM3263705", "GSM3263706", "GSM3263707", "GSM3263708", "GSM3263709", "GSM3263710", "GSM3263711", "GSM3263712", "GSM3263713", "GSM3263714", "GSM3263715", "GSM3263716", "GSM3263717", "GSM3263718", "GSM3263719", "GSM3263720", "GSM3263721", "GSM3263722", "GSM3263723", "GSM3263724", "GSM3263725", "GSM3263726", "GSM3263727", "GSM3263728", "GSM3263729", "GSM3263730", "GSM3263731", "GSM3263732", "GSM3263733", "GSM3263734", "GSM3263735", "GSM3263736", "GSM3263737", "GSM3263738", "GSM3263739", "GSM3263740", "GSM3263741", "GSM3263742", "GSM3263743", "GSM3263744", "GSM3263745", "GSM3263746", "GSM3263747", "GSM3263748", "GSM3263749", "GSM3263750", "GSM3263751", "GSM3263752", "GSM3263753", "GSM3263754", "GSM3263755", "GSM3263756", "GSM3263757", "GSM3263758", "GSM3263759", "GSM3263760", "GSM3263761", "GSM3263762", "GSM3263763", "GSM3263764", "GSM3263765", "GSM3263766", "GSM3263767", "GSM3263768", "GSM3263769", "GSM3263770", "GSM3263771", "GSM3263772", "GSM3263773", "GSM3263774", "GSM3263775", "GSM3263776", "GSM3263777", "GSM3263778", "GSM3263779", "GSM3263780", "GSM3263781", "GSM3263782", "GSM3263783", "GSM3263784", "GSM3263785", "GSM3263786", "GSM3263787", "GSM3263788", "GSM3263789", "GSM3263790", "GSM3263791", "GSM3263792", "GSM3263793", "GSM3263794", "GSM3263795", "GSM3263796", "GSM3263797", "GSM3263798", "GSM3263799", "GSM3263800", "GSM3263801", "GSM3263802", "GSM3263803", "GSM3263804", "GSM3263805", "GSM3263806", "GSM3263807", "GSM3263808", "GSM3263809", "GSM3263810", "GSM3263811", "GSM3263812", "GSM3263813", "GSM3263814", "GSM3263815", "GSM3263816", "GSM3263817", "GSM3263818", "GSM3263819", "GSM3263820", "GSM3263821", "GSM3263822", "GSM3263823", "GSM3263824", "GSM3263825", "GSM3263826", "GSM3263827", "GSM3263828", "GSM3263829", "GSM3263830", "GSM3263831", "GSM3263832", "GSM3263833", "GSM3263834", "GSM3263835", "GSM3263836", "GSM3263837", "GSM3263838", "GSM3263839", "GSM3263840", "GSM3263841", "GSM3263842", "GSM3263843", "GSM3263844", "GSM3263845", "GSM3263846", "GSM3263847", "GSM3263848", "GSM3263849", "GSM3263850", "GSM3263851", "GSM3263852", "GSM3263853", "GSM3263854", "GSM3263855", "GSM3263856", "GSM3263857", "GSM3263858", "GSM3263859", "GSM3263860", "GSM3263861", "GSM3263862", "GSM3263863", "GSM3263864", "GSM3263865", "GSM3263866", "GSM3263867", "GSM3263868", "GSM3263869", "GSM3263870", "GSM3263871", "GSM3263872", "GSM3263873", "GSM3263874", "GSM3263875", "GSM3263876", "GSM3263877", "GSM3263878", "GSM3263879", "GSM3263880", "GSM3263881", "GSM3263882", "GSM3263883", "GSM3263884", "GSM3263885", "GSM3263886", "GSM3263887", "GSM3263888", "GSM3263889", "GSM3263890", "GSM3263891", "GSM3263892", "GSM3263893", "GSM3263894", "GSM3263895", "GSM3263896", "GSM3263897", "GSM3263898", "GSM3263899", "GSM3263900", "GSM3263901", "GSM3263902", "GSM3263903", "GSM3263904", "GSM3263905", "GSM3263906", "GSM3263907", "GSM3263908", "GSM3263909", "GSM3263910", "GSM3263911"], "sample_count": 248, "group_sizes": null, "group_sizes_basis": null, "platform": "25318", "taxon": "Homo sapiens", "title": "Using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE116918 not downloaded", "asset:data:geo:GSE116918 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Then, lasso (least absolute shrinkage and selection operator) [23] Cox regression analysis was adopted for this prognostic signature construction by using R package “glmnet.”"}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}, {"id": "method-3", "family": "diagnostic_evaluation", "specific": "roc", "label": "Diagnostic test evaluation", "dsl_operations": ["confusion_counts", "roc_curve", "sensitivity_specificity", "solve_confusion_matrix", "classification_metrics", "published_precision_envelope"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["reference_standard_and_test"], "evidence": {"score": 0.7, "band": "medium", "quote": "ROC curve"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE116918"], "resolved_accessions": ["GSE116918"], "statements": ["The data could be acquired from TCGA dataset (https://portal.gdc.cancer.gov/) and GEO dataset (https://www.ncbi.nlm.nih.gov/geo/). The data of drug sensitivity could be acquired from the CellMiner database (https://discover.nci.nih.gov/cellminer). The code used in the study is available from the corresponding author on reasonable request."], "basis": "The paper names GSE116918 in GEO and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:35602299", "data:geo:GSE116918"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE116918"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T17:47:02Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 12677, "completion_tokens": 3033, "cached_tokens": 256}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:35602299", "type": "paper", "label": "pmid:35602299"}, {"id": "source:pmid:35602299", "type": "manuscript", "label": "PMID 35602299 full text"}, {"id": "data:geo:GSE116918", "type": "dataset", "label": "GEO GSE116918"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:35602299", "type": "paper", "label": "pmid:35602299"}, {"id": "source:pmid:35602299", "type": "manuscript", "label": "PMID 35602299 full text"}, {"id": "data:geo:GSE116918", "type": "dataset", "label": "GEO GSE116918"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-35602299", "type": "extraction", "used": ["source:pmid:35602299"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE116918", "type": "accession_resolution", "used": ["data:geo:GSE116918"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:35602299", "parent_hash": "sha256:509d453f1ddf21ae7fcbcb0ab76ed30304387b6576c4f5b7c798b260990a3253", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:GSE116918 licence not read", "asset:data:geo:GSE116918 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["Gene Set Enrichment Analysis) website. Then, RNA-seq (RNA sequencing) and clinical data from TCGA", "Enrichment Analysis) website. Then, RNA-seq (RNA sequencing) and clinical data from TCGA-PRAD (The Cance"], "order_basis": "paper_text_order:783", "id": "assay:1"}, {"role": "data_generation", "definition_id": "ihc", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.93, "evidence": ["signature and clinical features of PRAD. (g) Immunohistochemistry figures from The Human Protein Atlas databas"], "order_basis": "paper_text_order:3500", "id": "assay:2"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Then, lasso (least absolute shrinkage and selection operator) [23] Cox regression analysis was adopted for this prognostic signature construction by using R package “glmnet.”"], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}